Generate Biomedicines on Thursday said it has raised another $273 million to fund its pipeline of drugs for autoimmune disorders, cancers and infectious diseases. The startup, incubated by Flagship ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results